Predicting Tipifarnib Response In T-Cell Nhl

Predicting tipifarnib response in T-cell NHL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Foss on Tipifarnib in Relapsed, Refractory, T-Cell Lymphoma

Blood Cancers Today

New Prognostic Model Predicts CNS Relapse in Patients With T-Cell Lymphomas

Blood Cancers Today

T-cell Lymphoma

Novel treatment strategies in T-cell lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

Understanding & predicting outcomes in CAR T-cell therapy for aggressive lymphoma | Steven Bair, MD

University of Colorado | Department of Medicine

Pre-clinical activity of tipifarnib in CTCL

VJHemOnc – Video Journal of Hematology & HemOnc

The future of valemetostat in PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

Activated T cell attacks a cancer cell

Nanolive, Looking inside life

Predicting and Analyzing Response in Follicular Lymphoma

Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Lymphoma: predicting response

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Flinn on CAR T-Cell Therapy in Non-Hodgkin Lymphoma

Macrophage vs lymphoma

Nanolive, Looking inside life

Using PET to predict failure to salvage therapy in patients with DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

T-cell lymphoma registries: What have we learned?

MDedge: news and insights for busy physicians

Recent advances in the management of lymphoma

Sunnybrook Hospital

What You Need to Know About CAR T-Cell Therapy in NHL: A Deep Dive

Using models to predict progression in follicular lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Quality of Life at Diagnosis May Predict Survival for Patients With Aggressive Lymphoma